Gene therapy may offer significant advantages in prevention and treatment of botulism exposure over current methods, new research shows. "We envision this treatment approach having a broad range of applications such as protecting military personnel from biothreat agents or protecting the public from other toxin-mediated diseases such as C. difficile and Shiga toxin-producing E. coli infections," said the lead researcher.